Q4 2015 Holdings
Filed 2016-02-16 | 37 holdings | $195.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $69.1M | 2,564,553 | 35.3% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $31.9M | 3,094,064 | 16.3% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $30.6M | 1,671,447 | 15.7% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $29.2M | 1,272,048 | 14.9% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $23.6M | 857,683 | 12.1% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $10.4M | 571,444 | 5.3% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $121.1K | 11,222,893 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $113.1K | 7,088,651 | 0.1% |
| Dyax Corp | COM | 26746E103 | $102.2K | 2,717,618 | 0.1% |
| Axovant Sciences LTD | COM | G0750W104 | $90.2K | 5,000,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $33.6K | 2,813,779 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $33.2K | 2,253,237 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $30.4K | 3,482,924 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $28.8K | 2,428,571 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $23.1K | 878,348 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $22.9K | 1,476,931 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $20.4K | 2,690,702 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $20.2K | 1,619,977 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $20.2K | 2,212,036 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $20.2K | 1,174,219 | 0.0% |
| Alcobra LTD | SHS | M2239P109 | $19.0K | 3,032,911 | 0.0% |
| Arena Pharmaceutical S Inc | COM | 040047102 | $16.6K | 8,714,482 | 0.0% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $14.8K | 457,142 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $14.6K | 790,200 | 0.0% |
| Dimension Therapeutics Inc | COM | 25433V105 | $12.3K | 1,087,930 | 0.0% |
| Pronai Therapeutics Inc | COM | 74346L101 | $9.1K | 604,982 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $8.5K | 783,520 | 0.0% |
| Tenax Therapeutics Inc | COM | 88032L100 | $7.8K | 2,389,700 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $5.8K | 321,161 | 0.0% |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | $5.1K | 507,191 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $4.8K | 236,059 | 0.0% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $4.7K | 612,863 | 0.0% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $3.8K | 263,921 | 0.0% |
| Arca Biopharma Inc | COM PAR$.001 | 00211Y407 | $3.6K | 778,211 | 0.0% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $2.9K | 641,236 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $2.5K | 144,671 | 0.0% |
| Ampliphi Biosciences Corp | COM NEW | 03211P202 | $213 | 53,600 | 0.0% |